Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Morning Alexa Flash Briefings of February 27th
Alexa Flash Briefings
Cheddar Morning News Briefings of February 27th
Cheddar Morning News Briefings
The Week Ahead: Retail Earnings and Pending Home Sales
The Week Ahead: Retail Earnings and Pending Home Sales.
New Home Sales Rise as Housing Market Slows
New home sales rise as housing market slows.
Loreen Gilbert Talks State of Inflation
Loreen Gilbert, Wealthwise president, talks the state of inflation.
Analyst: Apple To Release VR Headset By 2025
Apple will release a VR headset in 2025, according to a company analyst.
Ford Halts F-150 Production For Another Week
Ford halted production for its F-150 Lightning electric truck for another week, linked to a continuing battery flaw.
eDRV Offers EV Charging Management Solution
EV charging solution eDRV recently announced it closed a seed funding round. Bhaskar Deol, co-founder and CEO of eDRV, joined Cheddar News to explain how his company helps to launch and manage charging networks.
The Week's Top Stories: Nvidia AI, Inflation Flare & Retail Uncertainty
The Week's Top Stories is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
